RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,780.00
+190.00 (3.40%)
At close: Aug 24, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 48.44 billion as of August 21, 2026. Its market cap has decreased by -13.33% in one year.
Market Cap
48.44B
Enterprise Value
47.93B
Revenue
141.42B
Ranking
n/a
PE Ratio
7.19
Stock Price
5,780.00
ChartMarket Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 48.44B, a decrease of -66.16%. That is a compound annual growth rate of -24.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 48.44B | -24.46% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sinil Pharmaceutical | 66.21B |
| Pharos iBio | 65.89B |
| GL Pharm Tech | 65.22B |
| BL Pharmtech | 54.06B |
| Jin Yang Pharmaceutical | 50.93B |
| Samik Pharmaceutical Company LTD. | 49.58B |
| Organoidsciences | 45.44B |
| GeneBioTech Co. ,Ltd | 40.17B |